Skip to main content

Table 4 Univariate and multivariate associations between covariates and the composite primary endpoint of recurrence or dead in CRC patients with stage II/III

From: Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer

Characteristic

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

IOC

 Did not receive

1.0 (reference)

 

1.0(reference)

 

 Received

0.53(0.32–0.86)

.01

0.50(0.30–0.82)

.006

Gender

 Female

1.0(reference)

 

1.0(reference)

 

 Male

1.31(0.80–2.13)

.29

1.37(0.83–2.27)

.22

Age

 <50

1.0(reference)

 

1.0(reference)

 

 ≥50

1.54(0.71–3.34)

.28

1.50(0.67–3.32)

.33

Tumor location

 Right colon

1.0(reference)

 

1.0(reference)

 

 Left colon

1.42(0.75–2.69)

.28

1.33(0.68–2.59)

.40

 Rectal

1.11(0.63–1.95)

.71

0.92(0.51–1.66)

.78

Tumor size

 <5 cm

1.0(reference)

 

1.0(reference)

 

 ≥5cm

1.01(0.64–1.58)

.97

1.13(0.70–1.81)

.62

Pathologic N category

 N0

1.0(reference)

 

1.0(reference)

 

 N1

2.12(1.24–3.61)

.006

2.23(1.23–4.05)

.008

 N2

2.64(1.39–5.00)

.003

2.84(1.37–5.88)

.005

TNM stage

 II

1.0(reference)

 

1.0(reference)

 

 III

2.26(1.37–3.73)

.002

2.37(1.33–4.20)

.003

Differentiation

 Well

1.0(reference)

 

1.0(reference)

 

 Moderate

0.88(0.22–3.59)

.86

0.44(0.10–1.94)

.28

 Poor

0.80(0.15–4.38)

.80

0.33(0.05–2.05)

.24

Vascular invasion

 No

1.0(reference)

 

1.0(reference)

 

 Yes

1.55(0.99–2.43)

.06

1.34(0.81–2.22)

.26

ASA

 II

1.0(reference)

 

1.0(reference)

 

 III/IV

1.29(0.83–2.03)

.26

1.54(0.96–2.49)

.07

POC

 Did not receive

1.0(reference)

 

1.0(reference)

 

 Received

0.66(0.42–1.04)

.07

0.53(0.33–0.85)

.009

  1. Abbreviation: IOC Intraoperative intraperitoneal chemotherapy, ASA American Society of Anesthesiologists